Muscle preservation during weight loss with GLP-1 drugs
Part of Hormones & metabolism clinical trials.
This trial tests a special medical food to help keep muscle mass while losing weight with GLP-1 medications like liraglutide, semaglutide, or tirzepatide. It's for adults with obesity or overweight with related health issues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You have a BMI of 30 or higher, or a BMI of 27 or higher with a weight-related health problem (like high blood pressure, prediabetes, or sleep apnea)
- You have just started (or will start within 2 weeks) a GLP-1 weight-loss drug such as liraglutide, semaglutide, or tirzepatide
- You are willing to adjust your diet to include specific protein levels based on your ideal body weight
- You do not have diabetes (type 1 or 2), severe kidney problems, or active cancer
- You are not pregnant or breastfeeding, and you agree to avoid certain amino acid or HMB supplements unless you stop them 15 days before starting
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a 12-week program of exercise and personalized nutrition counseling can help obese adults maintain muscle and bone while taking GLP-1 medications (drugs that help with weight loss). GLP-1 drugs can sometimes cause muscle loss, so this trial explores whether targeted exercise and nutrition can prevent that.
This trial compares two ways to manage weight: taking a GLP-1 medication (like tirzepatide or semaglutide) versus making lifestyle changes without medication. It will help researchers learn which approach works best for people with overweight or obesity.
This trial tests whether adding resistance exercise and extra protein can help you keep your muscle while taking weight loss medications like semaglutide or tirzepatide. It is for people with a BMI of 27 or higher who are not already exercising regularly.
This study looks at whether exercise can help prevent muscle loss in people taking GLP-1 medications (like Wegovy, Ozempic, or Mounjaro) for weight loss. It may help you keep your muscles strong while you lose weight.
This trial tests a weight-loss medication (GLP-1 receptor agonist) combined with dietary protein to see if it helps protect muscle while losing fat. It is for adults with obesity who are not taking certain other medications or supplements.
This trial tests a new medicine, (S)-pindolol benzoate, given along with semaglutide (Ozempic/Wegovy). The goal is to see if it helps people lose mostly fat instead of muscle while on a weight loss program.
Hear when a new Obesity & Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.